Every SEC Form 3/4/5 on record for this filer (CIK 1542517) — 1 issuer, 127 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ADMA | ADMA BIOLOGICS, INC. | President and CEO · Director | 2015-10-14 → 2026-03-17 | 67 | −$17M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| ADMA | 2026-03-16 | Sell | 15,000 | $15.16 | $227,400 | 2,118,777 |
| ADMA | 2026-03-16 | Sell | 6,000 | $15.16 | $90,960 | 2,112,777 |
| ADMA | 2026-02-17 | Sell | 15,000 | $16.08 | $241,200 | 2,290,379 |
| ADMA | 2026-02-17 | Sell | 6,000 | $16.08 | $96,480 | 2,284,379 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.